Erste Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-44,700	Closed	-$147K	–	809
2025 Q3	$147K	Hold	44,700	–	–	﹤0.01%	569
2025 Q2	$113K	Hold	44,700	–	–	﹤0.01%	817
2025 Q1	$339K	Hold	44,700	–	–	﹤0.01%	452
2024 Q4	$525K	Hold	44,700	–	–	0.01%	437
2024 Q3	$825K	Hold	44,700	–	–	0.01%	395
2024 Q2	$958K	Hold	44,700	–	–	0.01%	376
2024 Q1	$1.22M	Buy	44,700 +28,000	+168%	+$795K	0.02%	354
2023 Q4	$516K	Hold	16,700	–	–	0.01%	420
2023 Q3	$346K	Hold	16,700	–	–	0.01%	446
2023 Q2	$335K	Hold	16,700	–	–	0.01%	457
2023 Q1	$272K	Hold	16,700	–	–	0.01%	476
2022 Q4	$326K	Hold	16,700	–	–	0.01%	454
2022 Q3	$234K	Hold	16,700	–	–	0.01%	486
2022 Q2	$218K	Hold	16,700	–	–	﹤0.01%	507
2022 Q1	$266K	Hold	16,700	–	–	0.01%	491
2021 Q4	$379K	Hold	16,700	–	–	0.01%	446
2021 Q3	$500K	Hold	16,700	–	–	0.01%	409
2021 Q2	$724K	Hold	16,700	–	–	0.01%	375
2021 Q1	$724K	Hold	16,700	–	–	0.02%	355
2020 Q4	$933K	Buy	+16,700	New	+$609K	0.03%	344

Other funds holding RCKT